{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:44:00Z","timestamp":1792806240882,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0842-4","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T04:46:08Z","timestamp":1457671568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"Geng-yuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-wei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"842_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"842_CR2","first-page":"552","volume":"6","author":"D Camacho","year":"2005","unstructured":"Camacho D, Reichenbach D, Duerr GD, Venema TL, Sweeney JF, Fisher WE. Value of laparoscopy in the staging of pancreatic cancer. JOP. 2005;6:552\u201361.","journal-title":"JOP"},{"key":"842_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"842_CR4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/jcb.24038","volume":"113","author":"RS Redis","year":"2012","unstructured":"Redis RS, Berindan-Neagoe I, Pop VI, Calin GA. Non-coding RNAs as theranostics in human cancers. J Cell Biochem. 2012;113:1451\u20139.","journal-title":"J Cell Biochem"},{"key":"842_CR5","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1158\/0008-5472.CAN-09-0309","volume":"69","author":"Y Wang","year":"2009","unstructured":"Wang Y, Blelloch R. Cell cycle regulation by microRNAs in embryonic stem cells. Cancer Res. 2009;69:4093\u20136.","journal-title":"Cancer Res"},{"key":"842_CR6","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4161\/cc.6.17.4641","volume":"6","author":"M Carleton","year":"2007","unstructured":"Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle. 2007;6:2127\u201332.","journal-title":"Cell Cycle"},{"key":"842_CR7","doi-asserted-by":"crossref","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257\u201361.","DOI":"10.1073\/pnas.0510565103"},{"key":"842_CR8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ejca.2007.04.002","volume":"43","author":"EA Wiemer","year":"2007","unstructured":"Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer. 2007;43:1529\u201344.","journal-title":"Eur J Cancer"},{"key":"842_CR9","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3892\/or.2015.3931","volume":"33","author":"J Xu","year":"2015","unstructured":"Xu J, Zhang W, Lv Q, Zhu D. Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN. Oncol Rep. 2015;33:3108\u201316.","journal-title":"Oncol Rep"},{"key":"842_CR10","doi-asserted-by":"crossref","unstructured":"Ma X, Conklin DJ, Li F, Dai Z, Hua X, Li Y, Xu-Monette ZY, Young KH, Xiong W, Wysoczynski M, et al: The oncogenic microRNA miR-21 promotes regulated necrosis in mice. Nat Commun. 2015;6:7151.","DOI":"10.1038\/ncomms8151"},{"key":"842_CR11","first-page":"819","volume":"26","author":"Y Lou","year":"2010","unstructured":"Lou Y, Yang X, Wang F, Cui Z, Huang Y. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med. 2010;26:819\u201327.","journal-title":"Int J Mol Med"},{"key":"842_CR12","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","DOI":"10.1001\/jama.283.15.2008"},{"key":"842_CR13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.","journal-title":"Trials"},{"key":"842_CR14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"842_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"842_CR16","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719\u201348.","journal-title":"J Natl Cancer Inst"},{"key":"842_CR17","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11605-008-0584-x","volume":"12","author":"M Dillhoff","year":"2008","unstructured":"Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg. 2008;12:2171\u20136.","journal-title":"J Gastrointest Surg"},{"key":"842_CR18","doi-asserted-by":"crossref","unstructured":"Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, Leon LG, Pollina LE, Groen A, Falcone A, et al: MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res. 2010;70:4528\u201338.","DOI":"10.1158\/0008-5472.CAN-09-4467"},{"key":"842_CR19","doi-asserted-by":"crossref","unstructured":"Hwang JH, Voortman J, Giovannetti E, Steinberg SM, Leon LG, Kim YT, Funel N, Park JK, Kim MA, Kang GH, et al: Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One. 2010;5:e10630.","DOI":"10.1371\/journal.pone.0010630"},{"key":"842_CR20","doi-asserted-by":"crossref","unstructured":"Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR, Sansom OJ, Evans TR, McKay CJ, Oien KA: MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res. 2012;18:534\u201345.","DOI":"10.1158\/1078-0432.CCR-11-0679"},{"key":"842_CR21","doi-asserted-by":"crossref","unstructured":"Kadera BE, Li L, Toste PA, Wu N, Adams C, Dawson DW, Donahue TR: MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS One. 2013;8:e71978.","DOI":"10.1371\/journal.pone.0071978"},{"key":"842_CR22","doi-asserted-by":"crossref","unstructured":"Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G, Zhang C, et al: Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012;58:610\u20138.","DOI":"10.1373\/clinchem.2011.172767"},{"key":"842_CR23","doi-asserted-by":"crossref","unstructured":"Ma MZ, Kong X, Weng MZ, Cheng K, Gong W, Quan ZW, Peng CH: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res. 2013;32:71.","DOI":"10.1186\/1756-9966-32-71"},{"key":"842_CR24","doi-asserted-by":"crossref","unstructured":"Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H: Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol. 2012;25:112\u201321.","DOI":"10.1038\/modpathol.2011.142"},{"key":"842_CR25","doi-asserted-by":"crossref","unstructured":"Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykoudis PM, Polymeneas G, Voros D: Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas. 2013;42:67\u201371.","DOI":"10.1097\/MPA.0b013e3182592ba7"},{"key":"842_CR26","doi-asserted-by":"crossref","unstructured":"Wang P, Zhuang L, Zhang J, Fan J, Luo J, Chen H, Wang K, Liu L, Chen Z, Meng Z: The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL. Mol Oncol. 2013;7:334\u201345.","DOI":"10.1016\/j.molonc.2012.10.011"},{"key":"842_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13148-015-0166-1","volume":"7","author":"SA Dhayat","year":"2015","unstructured":"Dhayat SA, Abdeen B, Kohler G, Senninger N, Haier J, Mardin WA. MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II. Clin Epigenetics. 2015;7:132.","journal-title":"Clin Epigenetics"},{"key":"842_CR28","doi-asserted-by":"crossref","unstructured":"Khan K, Cunningham D, Peckitt C, Barton S, Tait D, Hawkins M, Watkins D, Starling N, Rao S, Begum R, et al: miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer erbitux, radiotherapy and UFT (PERU) trial. Oncotarget. 2016. doi: 10.18632\/oncotarget.7208 .","DOI":"10.18632\/oncotarget.7208"},{"key":"842_CR29","doi-asserted-by":"crossref","unstructured":"Xia X, Yang B, Zhai X, Liu X, Shen K, Wu Z, Cai J: Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. PLoS One. 2013;8:e80426.","DOI":"10.1371\/journal.pone.0080426"},{"key":"842_CR30","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.12659\/MSM.892096","volume":"20","author":"Z Wang","year":"2014","unstructured":"Wang Z, Cai Q, Jiang Z, Liu B, Zhu Z, Li C. Prognostic role of microRNA-21 in gastric cancer: a meta-analysis. Med Sci Monit. 2014;20:1668\u201374.","journal-title":"Med Sci Monit"},{"key":"842_CR31","doi-asserted-by":"crossref","first-page":"e0118647","DOI":"10.1371\/journal.pone.0118647","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhang Y, Pan C, Ma F, Zhang S. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. PLoS One. 2015;10:e0118647.","journal-title":"PLoS One"},{"key":"842_CR32","doi-asserted-by":"crossref","unstructured":"Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu K, Wei L, Chu M: The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol. 2013;43:813\u201320.","DOI":"10.1093\/jjco\/hyt084"},{"key":"842_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1477-7819-11-219","volume":"11","author":"R Que","year":"2013","unstructured":"Que R, Ding G, Chen J, Cao L. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol. 2013;11:219.","journal-title":"World J Surg Oncol"},{"key":"842_CR34","first-page":"663","volume":"4","author":"JY Yang","year":"2014","unstructured":"Yang JY, Sun YW, Liu DJ, Zhang JF, Li J, Hua R. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Am J Cancer Res. 2014;4:663\u201373.","journal-title":"Am J Cancer Res"},{"key":"842_CR35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1014778713034","volume":"6","author":"DF Hayes","year":"2001","unstructured":"Hayes DF, Isaacs C, Stearns V. Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia. 2001;6:375\u201392.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"842_CR36","first-page":"640168","volume":"2012","author":"Y Xu","year":"2012","unstructured":"Xu Y, Sun J, Xu J, Li Q, Guo Y, Zhang Q. miR-21 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer. Gastroenterol Res Pract. 2012;2012:640168.","journal-title":"Gastroenterol Res Pract"},{"key":"842_CR37","doi-asserted-by":"crossref","unstructured":"Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY: MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14:2348\u201360.","DOI":"10.1261\/rna.1034808"},{"key":"842_CR38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","volume":"133","author":"L Salmena","year":"2008","unstructured":"Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell. 2008;133:403\u201314.","journal-title":"Cell"},{"key":"842_CR39","first-page":"Ra235","volume":"10","author":"EC Chu","year":"2004","unstructured":"Chu EC, Tarnawski AS. PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit. 2004;10:Ra235\u2013241.","journal-title":"Med Sci Monit"},{"key":"842_CR40","doi-asserted-by":"crossref","unstructured":"Dong Y, Richards JA, Gupta R, Aung PP, Emley A, Kluger Y, Dogra SK, Mahalingam M, Wajapeyee N: PTEN functions as a melanoma tumor suppressor by promoting host immune response. Oncogene. 2014;33:4632\u201342.","DOI":"10.1038\/onc.2013.409"},{"key":"842_CR41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647\u201358.","journal-title":"Gastroenterology"},{"key":"842_CR42","doi-asserted-by":"crossref","unstructured":"Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, et al: The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001;107:789\u2013800.","DOI":"10.1016\/S0092-8674(01)00597-9"},{"key":"842_CR43","doi-asserted-by":"crossref","unstructured":"Reis ST, Pontes-Junior J, Antunes AA, Dall\u2019Oglio MF, Dip N, Passerotti CC, Rossini GA, Morais DR, Nesrallah AJ, Piantino C, et al: miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol. 2012;12:14.","DOI":"10.1186\/1471-2490-12-14"},{"key":"842_CR44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-015-2404-4","volume":"405","author":"W Zhao","year":"2015","unstructured":"Zhao W, Dong Y, Wu C, Ma Y, Jin Y, Ji Y. MiR-21 overexpression improves osteoporosis by targeting RECK. Mol Cell Biochem. 2015;405:125\u201333.","journal-title":"Mol Cell Biochem"},{"key":"842_CR45","doi-asserted-by":"crossref","first-page":"e103698","DOI":"10.1371\/journal.pone.0103698","volume":"9","author":"LF Xu","year":"2014","unstructured":"Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S, Navab R. MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One. 2014;9:e103698.","journal-title":"PLoS One"},{"key":"842_CR46","doi-asserted-by":"crossref","unstructured":"Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X, Zang WQ, Li M, Ma YY, Wang T, Zhao GQ: MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci. 2013;58:1863\u201370.","DOI":"10.1007\/s10620-013-2612-2"},{"key":"842_CR47","doi-asserted-by":"crossref","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, et al: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267\u201377.","DOI":"10.1001\/jama.297.3.267"},{"key":"842_CR48","doi-asserted-by":"crossref","unstructured":"Valle JW, Palmer D, Jackson R, Cox T, Neoptolemos JP, Ghaneh P, Rawcliffe CL, Bassi C, Stocken DD, Cunningham D, et al: Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol. 2014;32:504\u201312.","DOI":"10.1200\/JCO.2013.50.7657"},{"key":"842_CR49","doi-asserted-by":"crossref","unstructured":"Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C, Bourguignon LY: The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol Oncol. 2014;132:739\u201344.","DOI":"10.1016\/j.ygyno.2014.01.034"},{"key":"842_CR50","doi-asserted-by":"crossref","unstructured":"Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y, Liu X: Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer. Cancer Genet. 2014;207:214\u201320.","DOI":"10.1016\/j.cancergen.2014.04.003"},{"key":"842_CR51","doi-asserted-by":"crossref","unstructured":"Oue N, Anami K, Schetter AJ, Moehler M, Okayama H, Khan MA, Bowman ED, Mueller A, Schad A, Shimomura M, et al: High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int J Cancer. 2014;134:1926\u201334.","DOI":"10.1002\/ijc.28522"},{"key":"842_CR52","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhao L, Ischenko I, Bao Q, Schwarz B, Niess H, Wang Y, Renner A, Mysliwietz J, Jauch KW, et al: Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer. Target Oncol. 2015;10(4):535\u201348.","DOI":"10.1007\/s11523-015-0360-2"},{"key":"842_CR53","doi-asserted-by":"crossref","unstructured":"Toste PA, Li L, Kadera BE, Nguyen AH, Tran LM, Wu N, Madnick DL, Patel SG, Dawson DW, Donahue TR: p85alpha is a microRNA target and affects chemosensitivity in pancreatic cancer. J Surg Res. 2015;196:285\u201393.","DOI":"10.1016\/j.jss.2015.02.071"},{"key":"842_CR54","doi-asserted-by":"crossref","unstructured":"Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ, et al: Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res. 2012;18:1352\u201363.","DOI":"10.1158\/1078-0432.CCR-11-1539"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0842-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:15:44Z","timestamp":1718406944000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjso.com\/content\/14\/1\/82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0842-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]},"article-number":"82"}}